A private group of more than 60 physicians, med-tech operators, lawyers, patent attorneys and finance experts who jointly evaluate Israeli medical startups. Members invest according to their own preferences.
Selective by design. A limited, carefully vetted circle.
Israel produces world-class medical technology that global players consistently acquire. We invest in storm-weathered companies, after their technology has been validated and once we've confirmed they address a strong need in a large addressable market. We prefer to invest after the Seed round, as they approach the treacherous strait before their Series A. This is our opportunity.

Breakthroughs in medical devices and paradigm-changing patient care, diagnostics and therapeutics, separating the wheat from the chaff in a dense ecosystem.

Global med-tech players use M&A as a growth vehicle, repeatedly acquiring Israeli startups that went from good to great.

VCs leverage their scale and runway to diversify risk and shift toward growth-stage deals, leaving strong early companies underfunded. That's exactly where we invest.
A simple, transparent structure built for people who value both rigor and control. You choose each deal, one at a time.
Our members, well rooted in the market, often surface promising Israeli med-tech opportunities.
The group runs collective, institutional-quality due diligence.
Deal-by-deal. Invest in what you choose, or pass, individually.
Ongoing updates via a private, trusted community.
Full structure, terms and process shared privately with prospective members.
Our method and disciplines reduce the risk, bringing hundreds of years of combined, multidisciplinary experience into one room, across every startup stage, from bootstrapping to exit.
We keep our portfolio confidential. Members see the full roster after joining.
Membership is selective and by invitation. Please tell us about yourself; a member of our founding team will personally review your request and get back to you. We admit a limited number of members.